Transcranial Magnetic Simulation in the Treatment of Migraine

Overview

Journal Neurotherapeutics

Specialty Neurology

Date 2010 May 1

PMID 20430320

Citations 38

Authors

Richard B Lipton

Starr H Pearlman

Affiliations

Soon will be listed here.

Abstract

Transcranial magnetic stimulation (TMS) is a diagnostic and therapeutic modality that is being developed as both an acute and preventive treatment for migraine. TMS delivers a fluctuating magnetic field from the scalp surface to induce current in the subjacent cortex. Magnetic pulses are delivered one at a time in single-pulse TMS (sTMS) or as a train of pulses in repetitive TMS (rTMS). For most of its 30-year history, TMS has been delivered in clinical and research settings using large tabletop devices. Based on the theory that sTMS may disrupt cortical spreading depression, sTMS has been studied and shown to be effective as an acute treatment for migraine with aura. Subsequent work in animal models confirms that sTMS disrupts cortical spreading depression. To make outpatient self-treatment possible, a portable device has been developed for acute treatment of migraine with aura. Based on the theory that rTMS alters brain excitability and neurotransmitter activity, rTMS has been studied as a preventive migraine treatment. A small body of evidence suggests that rTMS may have a role, but further studies are needed. In this review, we summarize the data on TMS as a treatment of migraine, and we suggest directions for future research.

Citing Articles

Harnessing Brain Plasticity: The Therapeutic Power of Repetitive Transcranial Magnetic Stimulation (rTMS) and Theta Burst Stimulation (TBS) in Neurotransmitter Modulation, Receptor Dynamics, and Neuroimaging for Neurological Innovations.

Sharbafshaaer M, Cirillo G, Esposito F, Tedeschi G, Trojsi F Biomedicines. 2024; 12(11).

PMID: 39595072 PMC: 11592033. DOI: 10.3390/biomedicines12112506.

Design and Validation of Miniaturized Repetitive Transcranial Magnetic Stimulation (rTMS) Head Coils.

Abbasi S, Alluri S, Leung V, Asbeck P, Makale M Sensors (Basel). 2024; 24(5).

PMID: 38475120 PMC: 10934069. DOI: 10.3390/s24051584.

Evaluating noninvasive brain stimulation to treat overactive bladder in individuals with multiple sclerosis: a randomized controlled trial protocol.

Salazar B, Hoffman K, Lincoln J, Karmonik C, Rajab H, Helekar S BMC Urol. 2024; 24(1):20.

PMID: 38273296 PMC: 10809615. DOI: 10.1186/s12894-023-01358-8.

The roles, challenges, and merits of the p value.

Chen O, Bodelet J, Saraiva R, Phan H, Di J, Nagels G Patterns (N Y). 2023; 4(12):100878.

PMID: 38106615 PMC: 10724370. DOI: 10.1016/j.patter.2023.100878.

Non-Pharmacological Treatment of Primary Headaches-A Focused Review.

Licina E, Radojicic A, Jeremic M, Tomic A, Mijajlovic M Brain Sci. 2023; 13(10).

PMID: 37891800 PMC: 10605615. DOI: 10.3390/brainsci13101432.

References

Cutrer F, Sorensen A, Weisskoff R, Ostergaard L, Del Rio M, Lee E . Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol. 1998; 43(1):25-31. DOI: 10.1002/ana.410430108. View

Hadjikhani N, Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B . Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001; 98(8):4687-92. PMC: 31895. DOI: 10.1073/pnas.071582498. View

Gershon A, Dannon P, Grunhaus L . Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry. 2003; 160(5):835-45. DOI: 10.1176/appi.ajp.160.5.835. View

Kaptsan A, Yaroslavsky Y, Applebaum J, Belmaker R, Grisaru N . Right prefrontal TMS versus sham treatment of mania: a controlled study. Bipolar Disord. 2003; 5(1):36-9. DOI: 10.1034/j.1399-5618.2003.00003.x. View

Vikelis M, Mitsikostas D . The role of glutamate and its receptors in migraine. CNS Neurol Disord Drug Targets. 2007; 6(4):251-7. DOI: 10.2174/187152707781387279. View

Hoffman R, Gueorguieva R, Hawkins K, Varanko M, Boutros N, Wu Y . Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry. 2005; 58(2):97-104. DOI: 10.1016/j.biopsych.2005.03.041. View

Michael N, Gosling M, Reutemann M, Kersting A, Heindel W, Arolt V . Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci. 2003; 17(11):2462-8. DOI: 10.1046/j.1460-9568.2003.02683.x. View

Camprodon J, Martinez-Raga J, Alonso-Alonso M, Shih M, Pascual-Leone A . One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend. 2006; 86(1):91-4. DOI: 10.1016/j.drugalcdep.2006.06.002. View

Schoenen J, Wang W, Albert A, Delwaide P . Potentiation instead of habituation characterizes visual evoked potentials in migraine patients between attacks. Eur J Neurol. 2013; 2(2):115-22. DOI: 10.1111/j.1468-1331.1995.tb00103.x. View

10.

Prasko J, Zalesky R, Bares M, Horacek J, Kopecek M, Novak T . The effect of repetitive transcranial magnetic stimulation (rTMS) add on serotonin reuptake inhibitors in patients with panic disorder: a randomized, double blind sham controlled study. Neuro Endocrinol Lett. 2007; 28(1):33-8. View

11.

Bohotin V, Fumal A, Vandenheede M, Gerard P, Bohotin C, Maertens de Noordhout A . Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine. Brain. 2002; 125(Pt 4):912-22. DOI: 10.1093/brain/awf081. View

12.

Clarke B, Upton A, Kamath M, Al-Harbi T, Castellanos C . Transcranial magnetic stimulation for migraine: clinical effects. J Headache Pain. 2006; 7(5):341-6. PMC: 3468174. DOI: 10.1007/s10194-006-0329-8. View

13.

Takeuchi N, Tada T, Toshima M, Matsuo Y, Ikoma K . Repetitive transcranial magnetic stimulation over bilateral hemispheres enhances motor function and training effect of paretic hand in patients after stroke. J Rehabil Med. 2009; 41(13):1049-54. DOI: 10.2340/16501977-0454. View

14.

de Vries B, Frants R, Ferrari M, van den Maagdenberg A . Molecular genetics of migraine. Hum Genet. 2009; 126(1):115-32. DOI: 10.1007/s00439-009-0684-z. View

15.

Borich M, Arora S, Kimberley T . Lasting effects of repeated rTMS application in focal hand dystonia. Restor Neurol Neurosci. 2009; 27(1):55-65. PMC: 4456689. DOI: 10.3233/RNN-2009-0461. View

16.

Gawel M, Connolly J, ROSE F . Migraine patients exhibit abnormalities in the visual evoked potential. Headache. 1983; 23(2):49-52. DOI: 10.1111/j.1526-4610.1983.hed2302049.x. View

17.

Haut S, Bigal M, Lipton R . Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol. 2006; 5(2):148-157. PMC: 1457022. DOI: 10.1016/S1474-4422(06)70348-9. View

18.

Loo C, McFarquhar T, Mitchell P . A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol. 2007; 11(1):131-47. DOI: 10.1017/S1461145707007717. View

19.

Bolay H, Reuter U, Dunn A, Huang Z, Boas D, Moskowitz M . Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002; 8(2):136-42. DOI: 10.1038/nm0202-136. View

20.

Aurora S, Welch K, Al-Sayed F . The threshold for phosphenes is lower in migraine. Cephalalgia. 2003; 23(4):258-63. DOI: 10.1046/j.1468-2982.2003.00471.x. View